Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

Myelodysplastic syndromes are acquired bone marrow disorders predominating in the elderly and are characterized by ineffective hematopoiesis, progressive cytopenias, and risk of progression to acute myeloid leukemia. Lower-risk myelodysplastic syndromes most commonly manifest with symptomatic…

Lascia un commento